| Invitation to a conference call and live audio webcast: Novartis Q1 2014 Results April 24, 2014, 14:00 CEST |
We are pleased to invite you to a conference call and live audio webcast for the Novartis
Q1 2014 Presentation on Thursday, April 24, 2014
| Date: | April 24, 2014 | |
| Time: | 14:00 | Switzerland |
| 13:00 | UK | |
| 08:00 | New York | |
| Dial-in: | +41(0)22 592 7953 | Local - Geneva, Switzerland |
| +44(0)20 3427 1919 | Local - London, United Kingdom | |
| 1877 280 2342 | National free phone - USA | |
| +33(0)1 70 48 01 66 | Local - Paris, France | |
| +49(0)69 2222 10627 | Local - Frankfurt, Germany | |
| Participant Passcode: | 8332185 | |
| Webcast: | You may access the conference call as a live audio webcast on the internet on April 24, 2014 | |
| http://www.novartis.com/investors/event-calendar/index.shtml | ||
| The MP3 will be uploaded on our Webpage shortly after the end of the event | ||
| Investor & Media App | iTunes for the Novartis Investor & Media App | |
| http://itunes.apple.com/ch/app/novartis-investor-and-media/id495111183?l=en&mt=8 | ||
| Novartis Global Investor Relations / General phone: | +41 61 324 79 44 | |||
| Samir Shah / Global Head Investor Relations | +41 61 324 79 44 | |||
| Basel Office | North America Office | |||
| Pierre-Michel Bringer | +41 61 324 10 65 | Stephen Rubino | +1 862 778 83 01 | |
| Thomas Hungerbuehler | +41 61 324 84 25 | Susan Donofrio | +1 201 787 07 91 | |
| Isabella Zinck | +41 61 324 71 88 | |||
| e-mail: investor.relations@novartis.com www.novartis.com | ||||